These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

864 related items for PubMed ID: 28763548

  • 21. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH, Le WB, Chen N, Wang WM, Liu ZS, Liu D, Chen JH, Tian J, Fu P, Hu ZX, Zeng CH, Liang SS, Zhou ML, Zhang HT, Liu ZH.
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [Abstract] [Full Text] [Related]

  • 23. Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.
    Masutani K, Tsuchimoto A, Yamada T, Hirakawa M, Mitsuiki K, Katafuchi R, Hirakata H, Kitazono T, Tsuruya K, West Japan Study Group for Therapy of IgA Nephropathy Investigators.
    Clin Exp Nephrol; 2016 Dec; 20(6):896-903. PubMed ID: 26758039
    [Abstract] [Full Text] [Related]

  • 24. Role of proteinuria reduction in the progression of IgA nephropathy.
    Locatelli F, Pozzi C, Del Vecchio L, Bolasco PG, Fogazzi GB, Andrulli S, Melis P, Altieri P, Ponticelli C.
    Ren Fail; 2001 Dec; 23(3-4):495-505. PubMed ID: 11499564
    [Abstract] [Full Text] [Related]

  • 25. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
    Li P, Chen YZ, Lin HL, Ni ZH, Zhan YL, Wang R, Yang HT, Fang JA, Wang NS, Li WG, Sun XF, Chen XM.
    Trials; 2017 Apr 11; 18(1):170. PubMed ID: 28395659
    [Abstract] [Full Text] [Related]

  • 26. Association Between Tonsillectomy and Outcomes in Patients With Immunoglobulin A Nephropathy.
    Hirano K, Matsuzaki K, Yasuda T, Nishikawa M, Yasuda Y, Koike K, Maruyama S, Yokoo T, Matsuo S, Kawamura T, Suzuki Y.
    JAMA Netw Open; 2019 May 03; 2(5):e194772. PubMed ID: 31150076
    [Abstract] [Full Text] [Related]

  • 27. Corticosteroid therapy in IgA nephropathy.
    Lv J, Xu D, Perkovic V, Ma X, Johnson DW, Woodward M, Levin A, Zhang H, Wang H, TESTING Study Group.
    J Am Soc Nephrol; 2012 Jun 03; 23(6):1108-16. PubMed ID: 22539830
    [Abstract] [Full Text] [Related]

  • 28. Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation.
    Messina M, di Vico MC, Ariaudo C, Mazzucco G, Fop F, Segoloni GP, Biancone L.
    J Nephrol; 2016 Aug 03; 29(4):575-83. PubMed ID: 27217158
    [Abstract] [Full Text] [Related]

  • 29. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 03; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 30. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov 03; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 31. Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial.
    Li Y, Fu R, Gao J, Wang L, Duan Z, Tian L, Ge H, Ma X, Zhang Y, Li K, Xu P, Tian X, Chen Z.
    Sci Rep; 2022 Jan 07; 12(1):255. PubMed ID: 34996948
    [Abstract] [Full Text] [Related]

  • 32. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H, Muryan A, Young P, Forrester M, Iotti A, Pereyra H, Lombi F, Seminario O, Alonso M, Iotti R.
    Medicina (B Aires); 2007 Jan 07; 67(5):445-50. PubMed ID: 18051227
    [Abstract] [Full Text] [Related]

  • 33. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
    Min L, Wang Q, Cao L, Zhou W, Yuan J, Zhang M, Che X, Mou S, Fang W, Gu L, Zhu M, Wang L, Yu Z, Qian J, Ni Z.
    Oncotarget; 2017 Jul 18; 8(29):48375-48384. PubMed ID: 28415636
    [Abstract] [Full Text] [Related]

  • 34. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.
    Knoll GA, Fergusson D, Chassé M, Hebert P, Wells G, Tibbles LA, Treleaven D, Holland D, White C, Muirhead N, Cantarovich M, Paquet M, Kiberd B, Gourishankar S, Shapiro J, Prasad R, Cole E, Pilmore H, Cronin V, Hogan D, Ramsay T, Gill J.
    Lancet Diabetes Endocrinol; 2016 Apr 18; 4(4):318-26. PubMed ID: 26608067
    [Abstract] [Full Text] [Related]

  • 35. Corticotherapy response in primary IgA nephropathy.
    Novaretti N, Silva GE, Costa RS, Moysés Neto M, Vieira Neto OM, Romão EA, Coelho EB, Dantas M.
    J Bras Nefrol; 2013 Apr 18; 35(1):27-34. PubMed ID: 23598749
    [Abstract] [Full Text] [Related]

  • 36. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
    Zhong Z, Tang Y, Tan J, Tan L, Pei G, Qin W.
    Int Urol Nephrol; 2021 Jan 18; 53(1):121-127. PubMed ID: 32944888
    [Abstract] [Full Text] [Related]

  • 37. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
    Kaneko T, Arai M, Ikeda M, Morita M, Watanabe Y, Hirama A, Shimizu A, Tsuruoka S.
    Int Urol Nephrol; 2015 Nov 18; 47(11):1823-30. PubMed ID: 26433884
    [Abstract] [Full Text] [Related]

  • 38. Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy.
    Kim YC, Chin HJ, Koo HS, Kim S.
    PLoS One; 2013 Nov 18; 8(8):e71545. PubMed ID: 23977072
    [Abstract] [Full Text] [Related]

  • 39. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr 18; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

  • 40. In IgA nephropathy, oral methylprednisolone reduced adverse kidney outcomes but increased adverse events.
    Hsu CY, Hsu RK.
    Ann Intern Med; 2022 Sep 18; 175(9):JC105. PubMed ID: 36063554
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.